Financing, Equity Capital Markets

Ocular Therapeutix, Inc.

10/20
|
$80.5 Million
Piper Sandler served as bookrunner for Ocular Therapeutix, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma